These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6923744)

  • 21. Current concepts: pancreatic extracts.
    Littman A; Hanscom DH
    N Engl J Med; 1969 Jul; 281(4):201-4. PubMed ID: 4892805
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of malabsorption in cystic fibrosis: influence of recent developments on clinical practice.
    Littlewood JM
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S56-62; discussion S59-62. PubMed ID: 8869184
    [No Abstract]   [Full Text] [Related]  

  • 23. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
    Dutta SK; Hubbard VS; Appler M
    Dig Dis Sci; 1988 Oct; 33(10):1237-44. PubMed ID: 3168696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mismatch of duodenal deliveries of dietary fat and pancreatin from enterically coated microspheres.
    Meyer JH; Lake R
    Pancreas; 1997 Oct; 15(3):226-35. PubMed ID: 9336785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic enzyme supplements in cystic fibrosis.
    Morrison G; Morrison J; Redmond A; Byers C; McCracken K; Dodge JA
    Lancet; 1991 Dec 21-28; 338(8782-8783):1596-7. PubMed ID: 1683999
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of pancrease: crossover comparative study versus eurobiol in cystic fibrosis.
    Chazalette JP; Dain MP; Castaigne JP
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S46-8. PubMed ID: 3042939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative in vitro and in vivo studies of enteric-coated pancrelipase preparations for pancreatic insufficiency.
    Thomson M; Clague A; Cleghorn GJ; Shepherd RW
    J Pediatr Gastroenterol Nutr; 1993 Nov; 17(4):407-13. PubMed ID: 8145097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis.
    Heijerman HG; Lamers CB; Bakker W
    Ann Intern Med; 1991 Feb; 114(3):200-1. PubMed ID: 1984743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoalbuminemia at diagnosis as a marker for severe respiratory course in infants with cystic fibrosis identified by newborn screening.
    Abman SH; Reardon MC; Accurso FJ; Hammond KB; Sokol RJ
    J Pediatr; 1985 Dec; 107(6):933-5. PubMed ID: 3851839
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis.
    Mischler EH; Parrell S; Farrell PM; Odell GB
    Am J Dis Child; 1982 Dec; 136(12):1060-3. PubMed ID: 7148760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo and in vitro studies of microsphere pancreatic supplements.
    Littlewood JM; Kelleher J; Walters MP; Johnson AW
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S22-9. PubMed ID: 2457072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy.
    Pettei MJ; Leonidas JC; Levine JJ; Gorvoy JD
    J Pediatr; 1994 Oct; 125(4):587-9. PubMed ID: 7931879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fat gram target.
    Robinson P
    J Paediatr Child Health; 1997 Dec; 33(6):545. PubMed ID: 9484691
    [No Abstract]   [Full Text] [Related]  

  • 35. Nutritional management and pancreatic enzyme therapy in cystic fibrosis patients: state of the art in 1987 and projections into the future.
    George DE; Mangos JA
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S49-57. PubMed ID: 3042940
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients.
    Gan KH; Heijerman HG; Geus WP; Bakker W; Lamers CB
    Aliment Pharmacol Ther; 1994 Dec; 8(6):603-7. PubMed ID: 7696449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrosing colonopathy in cystic fibrosis: results of a case-control study.
    Smyth RL; Ashby D; O'Hea U; Burrows E; Lewis P; van Velzen D; Dodge JA
    Lancet; 1995 Nov; 346(8985):1247-51. PubMed ID: 7475715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
    Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic enzyme supplementation as acid-resistant microspheres versus enteric-coated granules in cystic fibrosis. A double placebo-controlled cross-over study.
    Petersen W; Heilmann C; Garne S
    Acta Paediatr Scand; 1987 Jan; 76(1):66-9. PubMed ID: 3551493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.
    Smyth RL; van Velzen D; Smyth AR; Lloyd DA; Heaf DP
    Lancet; 1994 Jan; 343(8889):85-6. PubMed ID: 7903780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.